OPRX
OptimizeRx Corp
Overview
OptimizeRx provides digital marketing technology and data solutions to pharmaceutical and life sciences companies to reach healthcare providers and patients.
OptimizeRx Corp is a Healthcare company operating in Health Information Services with a $87.8M market cap.
Most recent reported earnings: Q2 FY2026 (Aug 5, 2026).
21 earnings calls indexed on Spoken Alpha.
Behavioral analysis
Management language signature
Disclosures
Investor Relations
Extracted from SEC 10-K filing, 2026-06-21.
Transcripts
Recent earnings calls
Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.
- Q1 FY2026Earnings2026-05-1211 Q&A exchanges
- Q4 FY2025Earnings2026-03-0519 Q&A exchanges
- Q3 FY2025Earnings2025-11-0716 Q&A exchanges
- Q2 FY2025Earnings2025-08-0815 Q&A exchanges
- Q1 FY2025Earnings2025-05-1225 Q&A exchanges
- Q4 FY2024Earnings2025-03-1223 Q&A exchanges
- Q3 FY2024Earnings2024-11-1318 Q&A exchanges
- Q2 FY2024Earnings2024-08-0813 Q&A exchanges
- Q1 FY2024Earnings2024-05-1415 Q&A exchanges
- Q4 FY2023Earnings2024-03-2811 Q&A exchanges
- Q3 FY2023Earnings2023-11-0624 Q&A exchanges
- Q2 FY2023Earnings2023-08-1413 Q&A exchanges
- Q1 FY2023Earnings2023-05-1030 Q&A exchanges
- Q4 FY2022Earnings2023-03-0828 Q&A exchanges
- Q3 FY2022Earnings2022-11-0917 Q&A exchanges
- Q2 FY2022Earnings2022-08-0915 Q&A exchanges
- Q1 FY2022Earnings2022-05-0425 Q&A exchanges
- Q4 FY2021Earnings2022-02-2420 Q&A exchanges
- Q3 FY2021Earnings2021-11-0920 Q&A exchanges
- Q2 FY2021Earnings2021-08-0416 Q&A exchanges
- Q1 FY2021Earnings2021-05-0919 Q&A exchanges
History
Earnings history
- Q2 FY20262026-08-05EPS— vs $0.01—Rev— vs ——EODHD
| Period | Reported | EPS actual | EPS consensus | EPS surprise | Revenue actual | Revenue consensus | Rev. surprise | Source |
|---|---|---|---|---|---|---|---|---|
| Q2 FY2026 | 2026-08-05 | — | $0.01 | — | — | — | — | EODHD |
Source: EODHD. OPRX reported actuals as published; sparse fields render as —.
Track Record
SampleSpoken Alpha tracks OPRX's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Beats consensus 10/10 quarters but stock falls 80% of the time
SampleWhen a company consistently beats but the stock doesn't react, consensus is usually set too low or the buy-side number is materially above sell-side. Watch for guidance walk-downs ahead of the print.
Raised guidance 3 quarters in a row
SampleConsecutive raises tighten the bar quarter over quarter. Watch the most recent print for the magnitude of the beat — a smaller beat against a higher bar is the early signal that the regime is breaking.
Quarterly beats & misses
Sample| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2026 | $2.24 | $2.17 | +3.1% | +1.3% | +0.4% |
| Q4 FY2026 | $2.21 | $2.02 | +9.2% | +2.0% | +2.0% |
| Q3 FY2026 | $2.45 | $2.22 | +10.3% | -7.0% | -7.1% |
| Q2 FY2026 | $2.47 | $2.11 | +17.1% | -6.3% | -6.2% |
| Q1 FY2025 | $2.24 | $2.17 | +3.0% | -3.6% | -4.1% |
| Q4 FY2025 | $2.45 | $2.26 | +8.4% | -4.6% | -6.8% |
| Q3 FY2025 | $2.45 | $2.38 | +3.1% | -5.0% | -6.3% |
| Q2 FY2025 | $2.61 | $2.30 | +13.6% | -5.6% | -5.2% |
| Q1 FY2024 | $2.69 | $2.27 | +18.5% | -9.7% | -8.8% |
| Q4 FY2024 | $2.46 | $2.31 | +6.6% | -5.2% | -4.3% |
Guidance change history
Sample- Q1 FY2026Maintained2026-04-15
- Q4 FY2026Raised2026-13-15
- Q3 FY2026Raised2026-10-15
- Q2 FY2026Raised2026-07-15
- Q1 FY2025Maintained2025-04-15
- Q4 FY2025Raised2025-13-15
- Q3 FY2025Maintained2025-10-15
- Q2 FY2025Raised2025-07-15
Top executives
SampleSpoken Alpha builds an accountability record per executive — how the person's own guidance, language, and reactions have evolved across every call they've appeared on. The one-liners below are illustrative placeholder data pending the deviation v1 work. Click any name for the full role timeline and call appearance history.
- Stephen L SilvestroCEO10 mo20 callsCurrentSample
CEO since 2025 • 1/4 beats (25%) • last guidance raise Q3 FY2026
- Edward StelmakhCFO10 mo19 callsCurrentSample
CFO since 2025 • 2/4 beats (50%) • last guidance cut Q2 FY2026
- Brendan W MerrellCOO10 mono recorded callsCurrentSample
COO since 2025 • 3/4 beats (75%) • last call held guidance Q3 FY2026
- Andrew J D'silvaChief Business Officer10 mo8 callsCurrentSample
OTHER_C_SUITE since 2025 • 2/4 beats (50%) • last guidance cut Q1 FY2026
- Theresa GrecoChief Commercial Officer1 yr 1 mono recorded callsCurrentSample
OTHER_C_SUITE since 2025 • 2/4 beats (50%) • last guidance raise Q3 FY2026
- Doug BeschChief Product & Tech Officer8 mono recorded callsCurrentSample
OTHER since 2025 • 2/4 beats (50%) • last call held guidance Q2 FY2026
Peers
Other companies in Healthcare
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
For developers and AI agents
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for OPRX.
$ curl https://api.spokenalpha.com/v1/companies/OPRXFAQ
Frequently asked about OPRX
Where can I find OptimizeRx Corp's (OPRX) earnings call transcripts?
Spoken Alpha indexes OPRX's earnings call transcripts at https://spokenalpha.com/companies/OPRX. Each call links to attributed speakers and parsed analyst Q&A. OptimizeRx Corp's own investor relations page is at https://investors.optimizerx.com/.
When was OptimizeRx Corp's most recent earnings call?
OptimizeRx Corp (OPRX) held its most recent earnings call on 2026-05-12, covering fiscal Q1 2026.
What sector is OPRX in?
OptimizeRx Corp (OPRX) operates in the Healthcare sector (Health Information Services industry).